Synovate Healthcare launches first diabetes monitor in India

Company Brief

New Delhi, June 26, 2008

Synovate Healthcare, the healthcare arm of international market research agency, Synovate, today announced the launch of its India Diabetes Monitor – the first of its kind in the country.

The Synovate Healthcare India Diabetes Therapy Monitor will track drug-prescribing behaviour across different specialties which treat diabetes, and will allow prescription data to be linked with patient profiles. Following its launch in China last year, the Diabetes Therapy Monitor now covers the two countries with the greatest number of diabetes patients in the world. Future expansion of the monitor is expected for Australia later this year.

Commented Sabina Heinz, Associate Director of the Asia Pacific Diabetes Monitors, “The launch of the new monitor in India will provide clients with a unique source of patient and prescription data for one of the biggest diabetes markets in the world, as well as a service that offers syndicated data with customised deliverables”.

Added Monica Gangwani, Head of Synovate Healthcare India, “India is the diabetes capital of the world, with over 40 million Indians having diabetes. This development provides a huge opportunity for marketers in this therapeutic area. Synovate Healthcare’s Diabetes Monitor is a unique syndicated report which goes beyond conventional audit reports that are currently available in India, offering marketers very specific and detailed information on diabetes treatment and doctor’s perceptions about drugs and brands”.

Synovate Healthcare currently offers Global Therapy Monitors across 20 markets and 5 portfolios, entailing 13 different disease areas: Oncology, Metabolics (Diabetes), Antiviral (HIV, Hepatitis B and C), Autoimmune (Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis, Lupus, IBD, PsA/AS) and CNS (Bipolar, Schizophrenia).

For further information, please contact:

Sabina Heinz

Tel: +65 6333 1511

e-mail: sabina.heinz@synovate.com